These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 17022560)

  • 21. Evaluation of potential mechanisms underlying genotype-phenotype correlations in multiple endocrine neoplasia type 2.
    Mise N; Drosten M; Racek T; Tannapfel A; Pützer BM
    Oncogene; 2006 Oct; 25(50):6637-47. PubMed ID: 16715139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic aspects of familial thyroid cancer.
    Morrison PJ; Atkinson AB
    Oncologist; 2009 Jun; 14(6):571-7. PubMed ID: 19465682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The treatment of medullary thyroid cancer].
    Fujita T; Fujimori M
    Gan To Kagaku Ryoho; 2009 Oct; 36(10):1627-31. PubMed ID: 19838021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple cutaneous neuromas and macular amyloidosis associated with medullary thyroid carcinoma.
    Baykal C; Buyukbabani N; Boztepe H; Barahmani N; Yazganoglu KD
    J Am Acad Dermatol; 2007 Feb; 56(2 Suppl):S33-7. PubMed ID: 17097365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical manifestations of familial medullary thyroid carcinoma.
    Kameyama K; Okinaga H; Takami H
    Biomed Pharmacother; 2004; 58(6-7):348-50. PubMed ID: 15271414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The RET gene in multiple endocrine neoplasia type 2 (MEN 2)].
    Ito T; Shirahama S; Ogura K; Yamamoto S; Takami H
    Nihon Rinsho; 2004 May; 62(5):883-8. PubMed ID: 15148813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Analysis of mutations in the RET proto-oncogene in patients with medullary thyroid tumor].
    Amosenko FA; Brzhezovskiĭ VZh; Liubchenko LN; Shabanov MA; Kozlova VM; Vanushko VE; Kazubskaia TP; Gar'kavtseva RF; Kalinin VN
    Genetika; 2003 Jun; 39(6):847-54. PubMed ID: 12884527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RET oncogene mutations in 75 cases of familial medullary thyroid carcinoma in Japan.
    Kameyama K; Okinaga H; Takami H
    Biomed Pharmacother; 2004; 58(6-7):345-7. PubMed ID: 15271413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple endocrine neoplasia 2A due to a unique C609S RET mutation presents with pheochromocytoma and reduced penetrance of medullary thyroid carcinoma.
    Kinlaw WB; Scott SM; Maue RA; Memoli VA; Harris RD; Daniels GH; Porter DM; Belloni DR; Spooner ET; Ernesti MM; Noll WW
    Clin Endocrinol (Oxf); 2005 Dec; 63(6):676-82. PubMed ID: 16343103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of medullary thyroid carcinoma.
    Jiménez C; Hu MI; Gagel RF
    Endocrinol Metab Clin North Am; 2008 Jun; 37(2):481-96, x-xi. PubMed ID: 18502338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic testing in endocrinology: lessons learned from experience with multiple endocrine neoplasia type 2 (MEN2).
    Jimenez C; Gagel RF
    Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S150-7. PubMed ID: 15135800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple endocrine neoplasia.
    Miller JA; Norton JA
    Cancer Treat Res; 1997; 90():213-25. PubMed ID: 9367085
    [No Abstract]   [Full Text] [Related]  

  • 33. RET proto-oncogene mutations are restricted to codons 634 and 918 in mainland Chinese families with MEN2A and MEN2B.
    Zhou Y; Zhao Y; Cui B; Gu L; Zhu S; Li J; Liu J; Yin M; Zhao T; Yin Z; Yu C; Chen C; Wang L; Xiao B; Hong J; Zhang Y; Tang Z; Wang S; Li X; Ning G
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):570-6. PubMed ID: 17573899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the role of RET polymorphisms/haplotypes as modifier loci for MEN 2, and analysis of the correlation with the type of RET mutation in a series of Spanish patients.
    Fernández RM; Navarro E; Antiñolo G; Ruiz-Ferrer M; Borrego S
    Int J Mol Med; 2006 Apr; 17(4):575-81. PubMed ID: 16525712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Double germline mutations in the RET Proto-oncogene in MEN 2A and MEN 2B kindreds.
    Dvorakova S; Vaclavikova E; Ryska A; Cap J; Vlcek P; Duskova J; Kodetova D; Holub V; Novak Z; Bendlova B
    Exp Clin Endocrinol Diabetes; 2006 Apr; 114(4):192-6. PubMed ID: 16705552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulmonary Function in Patients With Multiple Endocrine Neoplasia 2B.
    Fuller S; Del Rivero J; Venzon D; Ilanchezhian M; Allen D; Folio L; Ling A; Widemann B; Fontana JR; Glod J
    J Clin Endocrinol Metab; 2020 Sep; 105(9):2919-28. PubMed ID: 32448901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple endocrine neoplasia type 2 syndrome presenting with bowel obstruction caused by intestinal neuroma: case report.
    Prabhu M; Khouzam RN; Insel J
    South Med J; 2004 Nov; 97(11):1130-2. PubMed ID: 15586612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pheochromocytomas in Multiple Endocrine Neoplasia Type 2.
    Tsang VH; Tacon LJ; Learoyd DL; Robinson BG
    Recent Results Cancer Res; 2015; 204():157-78. PubMed ID: 26494388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple Endocrine Neoplasia Type 2B Presents Early in Childhood but Often Is Undiagnosed for Years.
    Makri A; Akshintala S; Derse-Anthony C; Widemann B; Stratakis CA; Glod J; Lodish M
    J Pediatr; 2018 Dec; 203():447-449. PubMed ID: 30314660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple endocrine neoplasia type IIB.
    Schmidt N
    Can J Surg; 1996 Apr; 39(2):96-7. PubMed ID: 8769917
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.